Literature DB >> 19213735

ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase.

Thomas Tousseyn1, Amantha Thathiah, Ellen Jorissen, Tim Raemaekers, Uwe Konietzko, Karina Reiss, Elke Maes, An Snellinx, Lutgarde Serneels, Omar Nyabi, Wim Annaert, Paul Saftig, Dieter Hartmann, Bart De Strooper.   

Abstract

ADAM10 is involved in the proteolytic processing and shedding of proteins such as the amyloid precursor protein (APP), cadherins, and the Notch receptors, thereby initiating the regulated intramembrane proteolysis (RIP) of these proteins. Here, we demonstrate that the sheddase ADAM10 is also subject to RIP. We identify ADAM9 and -15 as the proteases responsible for releasing the ADAM10 ectodomain, and Presenilin/gamma-Secretase as the protease responsible for the release of the ADAM10 intracellular domain (ICD). This domain then translocates to the nucleus and localizes to nuclear speckles, thought to be involved in gene regulation. Thus, ADAM10 performs a dual role in cells, as a metalloprotease when it is membrane-bound, and as a potential signaling protein once cleaved by ADAM9/15 and the gamma-Secretase.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19213735      PMCID: PMC2670177          DOI: 10.1074/jbc.M805894200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion.

Authors:  Uwe Schlomann; Dirk Wildeboer; Ailsa Webster; Olga Antropova; Dagmar Zeuschner; C Graham Knight; Andrew J P Docherty; Marc Lambert; Lisa Skelton; Harald Jockusch; Jörg W Bartsch
Journal:  J Biol Chem       Date:  2002-10-07       Impact factor: 5.157

2.  Autolytic processing at Glu586-Ser587 within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity.

Authors:  Tiebang Kang; Hyun I Park; Yewseok Suh; Yun-Ge Zhao; Harald Tschesche; Qing-Xiang Amy Sang
Journal:  J Biol Chem       Date:  2002-10-18       Impact factor: 5.157

3.  Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase.

Authors:  Masashi Asai; Chinatsu Hattori; Beáta Szabó; Noboru Sasagawa; Kei Maruyama; Sei-ichi Tanuma; Shoichi Ishiura
Journal:  Biochem Biophys Res Commun       Date:  2003-01-31       Impact factor: 3.575

Review 4.  Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex.

Authors:  Bart De Strooper
Journal:  Neuron       Date:  2003-04-10       Impact factor: 17.173

5.  Subcellular fractionation of rat liver.

Authors:  S Fleischer; M Kervina
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

6.  L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity.

Authors:  M S Shearman; D Beher; E E Clarke; H D Lewis; T Harrison; P Hunt; A Nadin; A L Smith; G Stevenson; J L Castro
Journal:  Biochemistry       Date:  2000-08-01       Impact factor: 3.162

7.  A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE.

Authors:  C Brou; F Logeat; N Gupta; C Bessia; O LeBail; J R Doedens; A Cumano; P Roux; R A Black; A Israël
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

8.  A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1.

Authors:  J S Mumm; E H Schroeter; M T Saxena; A Griesemer; X Tian; D J Pan; W J Ray; R Kopan
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

Review 9.  ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions.

Authors:  T G Wolfsberg; P Primakoff; D G Myles; J M White
Journal:  J Cell Biol       Date:  1995-10       Impact factor: 10.539

10.  MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains.

Authors:  G Weskamp; J Krätzschmar; M S Reid; C P Blobel
Journal:  J Cell Biol       Date:  1996-02       Impact factor: 10.539

View more
  79 in total

1.  ADAM15 protein amplifies focal adhesion kinase phosphorylation under genotoxic stress conditions.

Authors:  Dorothee Fried; Beate B Böhm; Kristin Krause; Harald Burkhardt
Journal:  J Biol Chem       Date:  2012-04-27       Impact factor: 5.157

Review 2.  Regulation of α-secretase ADAM10 expression and activity.

Authors:  Kristina Endres; Falk Fahrenholz
Journal:  Exp Brain Res       Date:  2011-10-04       Impact factor: 1.972

3.  ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.

Authors:  Marcia L Moss; Gary Powell; Miles A Miller; Lori Edwards; Bin Qi; Qing-Xiang Amy Sang; Bart De Strooper; Ina Tesseur; Stefan F Lichtenthaler; Mara Taverna; Julia Li Zhong; Colin Dingwall; Taheera Ferdous; Uwe Schlomann; Pei Zhou; Linda G Griffith; Douglas A Lauffenburger; Robert Petrovich; Jörg W Bartsch
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

4.  Secreted and membrane-bound isoforms of protease ADAM9 have opposing effects on breast cancer cell migration.

Authors:  Jessica L Fry; Alex Toker
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

5.  Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators.

Authors:  Gillian Murphy
Journal:  Int J Exp Pathol       Date:  2010-08       Impact factor: 1.925

Review 6.  Targeting Notch to target cancer stem cells.

Authors:  Antonio Pannuti; Kimberly Foreman; Paola Rizzo; Clodia Osipo; Todd Golde; Barbara Osborne; Lucio Miele
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

7.  Sequential and gamma-secretase-dependent processing of the betacellulin precursor generates a palmitoylated intracellular-domain fragment that inhibits cell growth.

Authors:  Alexander Stoeck; Li Shang; Peter J Dempsey
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

Review 8.  Receptor tyrosine kinases in the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-10-01       Impact factor: 10.005

9.  Expression of ADAM10, Fas, FasL and Soluble FasL in Patients with Oral Squamous Cell Carcinoma (OSCC) and their Association with Clinical-Pathological Parameters.

Authors:  José Sergio Zepeda-Nuño; Celia Guerrero-Velázquez; Susana Del Toro-Arreola; Natali Vega-Magaña; Julián Ángeles-Sánchez; Jesse Haramati; Ana L Pereira-Suárez; Miriam R Bueno-Topete
Journal:  Pathol Oncol Res       Date:  2016-09-14       Impact factor: 3.201

Review 10.  Protease resistant protein cellular isoform (PrP(c)) as a biomarker: clues into the pathogenesis of HAND.

Authors:  Bezawit Megra; Eliseo Eugenin; Toni Roberts; Susan Morgello; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2013-04-25       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.